108 related articles for article (PubMed ID: 32314859)
1. New approach for stability study and determination of fluvoxamine in raw materials and pharmaceuticals through condensation with 2,2-dihydroxyindane-1,3-dione.
Abu-Hassan AA; Omar MA; Derayea SM
Luminescence; 2020 Sep; 35(6):934-940. PubMed ID: 32314859
[TBL] [Abstract][Full Text] [Related]
2. Use of acetylacetone for nano-level assay of fluvoxamine maleate in pure form and pharmaceutical formulation.
Abu-Hassan AA; Omar MA; Derayea SM
Luminescence; 2020 Dec; 35(8):1360-1365. PubMed ID: 32519373
[TBL] [Abstract][Full Text] [Related]
3. New validated spectrofluorimetric protocol for colistin assay through condensation with 2,2-dihydroxyindan-1,3-dione: application to content uniformity testing.
Attia TZ; Abdelmajed MA; Omar MA; Al Thagfan SS; Badr El-Din KM
RSC Adv; 2022 Nov; 12(52):33559-33566. PubMed ID: 36505680
[TBL] [Abstract][Full Text] [Related]
4. Spectrofluorimetric determination of fluvoxamine in dosage forms and plasma via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole.
Darwish IA; Amer SM; Abdine HH; Al-Rayes LI
J Fluoresc; 2009 May; 19(3):463-71. PubMed ID: 18949539
[TBL] [Abstract][Full Text] [Related]
5. Spectrofluorometric determination of fluvoxamine in dosage forms, spiked plasma, and real human plasma by derivatization with fluorescamine.
El-Enany N
J AOAC Int; 2007; 90(2):376-83. PubMed ID: 17474508
[TBL] [Abstract][Full Text] [Related]
6. Studying the association complex formation of atomoxetine and fluvoxamine with eosin Y and its application in their fluorimetric determination.
Derayea SM; Omar MA; Abu-Hassan AA
R Soc Open Sci; 2018 Mar; 5(3):170943. PubMed ID: 29657744
[TBL] [Abstract][Full Text] [Related]
7. Spectrofluorimetric analysis of gemifloxacin mesylate in pharmaceutical formulations.
Al-Tamimi SA; Alarfaj NA; Aly FA; Al-Mohaimeed AM
Luminescence; 2014 Mar; 29(2):127-31. PubMed ID: 23681953
[TBL] [Abstract][Full Text] [Related]
8. Development of a Green Microwell Spectrofluorimetric Assay with High Analytical Throughput for the Determination of Selective Serotonin Reuptake Inhibitors in Pharmaceutical Dosage Forms and Plasma.
Alzoman NZ; Darwish IA
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446883
[TBL] [Abstract][Full Text] [Related]
9. Design and strategy for spectrofluorimetric determination of tranexamic acid in its authentic form and pharmaceutical preparations: application to spiked human plasma.
Anwer EF; Nour El-Deen DAM; Omar MA
Luminescence; 2021 Aug; 36(5):1327-1334. PubMed ID: 33955136
[TBL] [Abstract][Full Text] [Related]
10. Development of spectrofluorimetric method for determination of certain antiepileptic drugs through condensation with ninhydrin and phenyl acetaldehyde.
Derayea SM; Attia TZ; Elnady M
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Nov; 204():48-54. PubMed ID: 29906646
[TBL] [Abstract][Full Text] [Related]
11. Stability-indicating spectrofluorimetric method for the assay of ziprasidone in capsules.
Walash MI; Belal F; El-Enany N; Eid M; El-Shaheny RN
J Fluoresc; 2011 Jul; 21(4):1659-67. PubMed ID: 21327537
[TBL] [Abstract][Full Text] [Related]
12. Highly sensitive spectrofluorimetric method for determination of doxazosin through derivatization with fluorescamine; Application to content uniformity testing.
Omar MA; Hammad MA; Salman BI; Derayea SM
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Mar; 157():55-60. PubMed ID: 26716887
[TBL] [Abstract][Full Text] [Related]
13. Selective spectrofluorimetric method for determination of Lisinopril in pharmaceutical preparations and in presence of hydrochlorothiazide: Application to content uniformity testing.
Derayea SM; Badr El-Din KM; Mohammed FF
Luminescence; 2017 Dec; 32(8):1482-1487. PubMed ID: 28681525
[TBL] [Abstract][Full Text] [Related]
14. Spectrophotometric and spectrofluorimetric determination of indacaterol maleate in pure form and pharmaceutical preparations: application to content uniformity.
El-Ashry SM; El-Wasseef DR; El-Sherbiny DT; Salem YA
Luminescence; 2015 Sep; 30(6):891-7. PubMed ID: 25620654
[TBL] [Abstract][Full Text] [Related]
15. A facile on-off fluorescence approach for fluvoxamine determination in pharmaceutical tablets; application to content uniformity testing.
Derayea SM; Oraby M; Zaafan AAS; Hamad AA; Nagy DM
RSC Adv; 2024 Mar; 14(12):8283-8292. PubMed ID: 38469194
[TBL] [Abstract][Full Text] [Related]
16. Determination of cefixime in pure form, in pharmaceutical products and biological samples through fluorescence quenching of eosin Y.
Khan MN; Irum ; Mursaleen M
Luminescence; 2021 Mar; 36(2):515-524. PubMed ID: 33140476
[TBL] [Abstract][Full Text] [Related]
17. Validated sensitive spectrofluorimetric method for determination of antihistaminic drug azelastine HCl in pure form and in pharmaceutical dosage forms: application to stability study.
El-Masry AA; Hammouda ME; El-Wasseef DR; El-Ashry SM
Luminescence; 2017 Mar; 32(2):177-181. PubMed ID: 27279096
[TBL] [Abstract][Full Text] [Related]
18. Selectivity Improvement for Spectrofluorimetric Determination of Oseltamivir Phosphate in Human Plasma and in the Presence of Its Degradation Product.
Omar MA; Derayea SM; Mostafa IM
J Fluoresc; 2017 Jul; 27(4):1323-1330. PubMed ID: 28293815
[TBL] [Abstract][Full Text] [Related]
19. Diaryl pyrrolone fluorescent probing strategy for Mirabegron determination through condensation with ninhydrin and phenylacetaldehyde: Application to dosage forms, human urine and plasma.
Derayea SM; Ahmed AS; Abdelshakour MA; Oraby M; Badr El-Din KM
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Oct; 318():124515. PubMed ID: 38810435
[TBL] [Abstract][Full Text] [Related]
20. A Stability Indicating HPLC Method for the Determination of Fluvoxamine in Pharmaceutical Dosage Forms.
Souri E; Donyayi H; Khaniha RA; Barazandeh Tehrani M
Iran J Pharm Res; 2015; 14(4):1059-65. PubMed ID: 26664372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
